Delsym and Benzonatate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Delsym (dextromethorphan polistirex) and Benzonatate (benzonatate). Common drug interactions include muscular weakness among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Delsym and Benzonatate. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Delsym?

Delsym has active ingredients of dextromethorphan polistirex. It is often used in cough. eHealthMe is studying from 5,033 Delsym users. Check the latest studies of Delsym.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

57 people who take Delsym and Benzonatate together, and have interactions are studied.

Delsym and Benzonatate drug interactions.

What are the common drug interactions of Delsym and Benzonatate, by gender? *:

female:

  1. Muscular weakness (muscle weakness)
  2. Neuropathy peripheral (surface nerve damage)
  3. Pain
  4. Renal disorder (kidney disease)
  5. Rib fracture
  6. Scab (a hard coating on the skin formed during the wound healing)
  7. Staring (a prolonged gaze or fixed look)
  8. Weight decreased
  9. Acne pustular (acne-white centre surrounded by red skin-skin disease)
  10. Arthralgia (joint pain)

male:

  1. Death
  2. Electrocardiogram qt prolonged
  3. Anxiety
  4. Chronic kidney disease
  5. Dizziness
  6. Emotional distress
  7. Gastrointestinal hypomotility (less activity of the intestinal tract)
  8. Pain
  9. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  10. Small intestinal obstruction (blockage in small intestine)

What are the common drug interactions of Delsym and Benzonatate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Haematochezia (passage of stools containing blood)
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Pyrexia (fever)
  5. Rash
  6. Vomiting

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. Hyperventilation
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

40-49:

  1. Hospitalisation
  2. Infusion site erythema (reddening of the skin at infusion site)
  3. Infusion site pruritus (severe itching at infusion site)
  4. Infusion site swelling
  5. Infusion site warmth
  6. Insomnia (sleeplessness)
  7. Malignant neoplasm progression (cancer tumour came back)
  8. Pyrexia (fever)
  9. Skin discolouration (change of skin colour)
  10. Skin exfoliation (removal of the oldest dead skin cells)

50-59:

  1. Pneumonia
  2. Fatigue (feeling of tiredness)
  3. Urinary tract infection
  4. Infection
  5. Asthma
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Electrocardiogram qt prolonged
  9. Feeling hot
  10. Impaired gastric emptying

60+:

  1. Death
  2. Fall
  3. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  4. Joint stiffness
  5. Limb injury
  6. Lung transplant
  7. Nausea (feeling of having an urge to vomit)
  8. Nephrolithiasis (calculi in the kidneys)
  9. Pneumonia
  10. Pruritus generalised (generalized itching)

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 17.54%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 15.79%
  3. High Blood Cholesterol: 9 people, 15.79%
  4. Constipation: 8 people, 14.04%
  5. Pain: 7 people, 12.28%
  6. Multiple Myeloma (cancer of the plasma cells): 7 people, 12.28%
  7. Immunodeficiency Common Variable: 7 people, 12.28%
  8. Asthma: 6 people, 10.53%
  9. Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 10.53%
  10. Cardiac Disorder: 6 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Delsym and Benzonatate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Delsym and Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Delsym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Delsym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benzonatate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dextromethorphan polistirex and benzonatate (the active ingredients of Delsym and Benzonatate, respectively), and Delsym and Benzonatate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: